Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « Y. Miwa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Y. Mekori < Y. Miwa < Y. Miyazaki  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
002B64 (2013) T. Kasama [Japon] ; M. Umemura [Japon] ; S. Isojima [Japon] ; T. Tokunaga [Japon] ; H. Tsukamoto [Japon] ; R. Yanai [Japon] ; H. Furuya [Japon] ; Y. Miwa [Japon]SAT0141 Correlation of Serum Macrophage Migration Inhibitory Factor Levels With Response to Tocilizumab Therapy in Patients with Rheumatoid Arthritis
003091 (2013) T. Kasama [Japon] ; K. Ohtsuka [Japon] ; R. Yanai [Japon] ; H. Furuya [Japon] ; M. Sato [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; Y. Miwa [Japon]AB0581 The relationship between macrophage migration inhibitory factor and clinical responsiveness to tocilizumab in patients with rheumatoid arthritis
003180 (2013) Y. Miwa [Japon] ; H. Furuya [Japon] ; R. Yanai [Japon] ; K. Ohtsuka [Japon] ; M. Sato [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; T. Kasama [Japon] ; M. Hosaka [Japon]AB0448 Factors leading to HAQ remission after beginning biologics treatment in patients with rheumatoid arthritis
003181 (2013) Y. Miwa [Japon] ; H. Furuya [Japon] ; R. Yanai [Japon] ; K. Ohtsuka [Japon] ; M. Sato [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; T. Kasama [Japon] ; M. Hosaka [Japon]AB0447 Comparison of efficacy of four biological agents for rheumatoid arthritis patients using the HRQOL questionnaire and depression scale
003274 (2013) Y. Miwa [Japon] ; S. Isojima [Japon] ; M. Umemura [Japon] ; H. Tsukamoto [Japon] ; T. Tokunaga [Japon] ; H. Furuya [Japon] ; R. Yanai [Japon] ; K. Otsuka [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; T. Kasama [Japon] ; M. Hosaka [Japon]AB0263 Correlation of cx3cl1 levels with adl, hrqol and depression to biologic agent therapy in patients with rheumatoid arthritis
003297 (2013) Y. Miwa [Japon] ; S. Isojima [Japon] ; M. Umemura [Japon] ; H. Tsukamoto [Japon] ; T. Tokunaga [Japon] ; H. Furuya [Japon] ; R. Yanai [Japon] ; K. Otsuka [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; T. Kasama [Japon] ; M. Hosaka [Japon]AB0200 Switching biologic agents in patients with rheumatoid arthritis: an observational study of 159 patients evaluating efficacy, adl, qol, and depression

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Y. Miwa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Y. Miwa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Y. Miwa
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021